Clinical Correlates of Treatment Response among Patients with Schizophrenia in a Tertiary Nigerian Hospital

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of health care for the poor and underserved

• Publication date

  2017-05-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1353/hpu.2017.0070PMID 28529220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Using the alcohol, smoking and Substance Involvement Screening Test (ASSIST) to determine substance abuse prevalence in the RI trauma population.

  2014cited by this paper
• Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study

  2012cited by this paper
• Medication adherence and quality of life among Nigerian outpatients with schizophrenia.

  2012cited by this paper
• Substance Misuse in Patients with Schizophrenia

  2012cited by this paper
• Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia

  2011cited by this paper
• Factors associated with medication adherence among psychiatric outpatients at substance abuse risk.

  2011cited by this paper
• Treatment resistant schizophrenia and response to antipsychotics: a review.

  2011cited by this paper
• Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus.

  2011cited by this paper
• Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.

  2011cited by this paper
• The Iowa Personality Disorder Screen (IPDS): Preliminary results of the validation of a self-administered version in a Dutch population

  2010cited by this paper
• The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

  2010cited by this paper
• Developing the World Health Organization Disability Assessment Schedule 2.0.

  2010cited by this paper
• Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation.

  2009cited by this paper
• Schizophrenia

  2009cited by this paper
• Psychiatric comorbidities and schizophrenia.

  2009cited by this paper
• The Self-Assessment Scale of Cognitive Complaints in Schizophrenia: A validation study in Tunisian population

  2009cited by this paper
• The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta analysis.

  2009cited by this paper
• Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs.

  2007cited by this paper
• Standardized Assessment of Psychopathology by Relatives of Mentally Disordered Patients

  2007cited by this paper
• Negative symptoms of schizophrenia: a problem that will not go away

  2007cited by this paper
• Treatment of schizophrenia negative symptoms: future prospects.

  2006cited by this paper
• The NIMH-MATRICS consensus statement on negative symptoms.

  2006cited by this paper
• Premorbid functioning and treatment response in recent-onset schizophrenia

  2006cited by this paper
• Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.

  2005cited by this paper
• Cannabis as a risk factor for psychosis: systematic review

  2005cited by this paper
• Cannabis use and the risk of later schizophrenia: a review.

  2004cited by this paper
• Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms.

  2004cited by this paper
• Treatment of Cognitive Dysfunction in Psychiatric Disorders

  2004cited by this paper
• An exploratory analysis of correlates of recovery.

  2004cited by this paper
• Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects.

  2004cited by this paper
• Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected.

  2003cited by this paper
• Premorbid factors in relation to motor, memory, and executive functions deficits in adult schizophrenia.

  2003cited by this paper
• Does dopamine sensitization underlie the association between schizophrenia and drug abuse?

  2003cited by this paper
• The frontal lobe neuropsychological tests in patients with schizophrenia and/or obsessive-compulsive disorder.

  2003cited by this paper
• Premorbid adjustment and neuropsychological performance in schizophrenia.

  2002cited by this paper
• Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis.

  2002cited by this paper
• Pharmacogenomics in schizophrenia: the quest for individualized therapy.

  2002cited by this paper
• Substance use disorders in schizophrenia: review, integration, and a proposed model.

  2000cited by this paper
• Cognitive impairment in schizophrenia

  2000cited by this paper
• Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study.

  2000cited by this paper
• Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia.

  1997cited by this paper
• The Suffolk County Mental Health Project: demographic, pre-morbid and clinical correlates of 6-month outcome

  1996cited by this paper
• Pharmacological treatment strategies in the non-responsive schizophrenic patient

  1996cited by this paper
• Conventional antipsychotic medications for schizophrenia.

  1995cited by this paper
• Heavy utilization of inpatient and outpatient services in a public mental health service.

  1995cited by this paper
• Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.

  1995cited by this paper
• Premorbid functioning in schizophrenia: a controlled study of Nigerian patients.

  1994cited by this paper
• Violent and destructive behavior among the severely mentally Ill in rural areas: Evidence from Arkansas' community mental health system

  1994cited by this paper
• Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis

  1993cited by this paper
• Psychopharmacologic treatment of schizophrenia.

  1993cited by this paper
• Long-term outcome of treated schizophrenia in a Nigerian cohort. Retrospective analysis of 7-year follow-ups.

  1993cited by this paper
• Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: a replication.

  1993cited by this paper
• The relationship of structural brain imaging parameters to antipsychotic treatment response: a review.

  1992cited by this paper
• Phenomenology and functioning in first-episode schizophrenia.

  1992cited by this paper
• Premorbid and onset features of first-episode schizophrenia.

  1992cited by this paper
• J Neuropsychiatry Clin Neurosci

  1992cited by this paper
• National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.

  1991cited by this paper
• Schizophrenics kill themselves too: a review of risk factors for suicide.

  1990cited by this paper
• Personality Disorder and Psychiatric Illness in General Practice

  1990cited by this paper
• The Significance of Depression in the Prediction of Relapse in Chronic Schizophrenia

  1988cited by this paper
• Characteristics of very poor outcome schizophrenia.

  1987cited by this paper
• Schizophrenia with Good and Poor Outcome. I: Early Clinical Features, Response to Neuroleptics and Signs of Organic Dysfunction

  1985cited by this paper
• Negative and deficit symptoms in schizophrenia do respond to neuroleptics.

  1985cited by this paper
• Early Subjective Response and Prediction of Outcome to Neuroleptic Drug Therapy in Schizophrenia

  1985cited by this paper
• Depression in Chronic Schizophrenia

  1983cited by this paper
• Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.

  1982cited by this paper
• Initial Improvement as Predictor of Outcome of Neuroleptic Treatment*

  1981cited by this paper
• A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia

  1978cited by this paper

• Incidence and factors associated of early non-response in first-treatment and drug-naïve patients with schizophrenia: a real-world study

  2023cites this paper
• White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study.

  2020cites this paper
• Antipsychotic Medication in Sub-Saharan Africa

  2020cites this paper
• Shared and distinct alterations of white matter tracts in remitted and nonremitted patients with schizophrenia

  2018cites this paper
• Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi

  2018cites this paper